Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer.
Valladares-Ayerbes M, Reboredo M, Medina-Villaamil V, Iglesias-Díaz P, Lorenzo-Patiño MJ, Haz M, Santamarina I, Blanco M, Fernández-Tajes J, Quindós M, Carral A, Figueroa A, Antón-Aparicio LM, Calvo L. Valladares-Ayerbes M, et al. Among authors: reboredo m. J Transl Med. 2012 Sep 6;10:186. doi: 10.1186/1479-5876-10-186. J Transl Med. 2012. PMID: 22954417 Free PMC article.
Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: a pilot study.
Valladares-Ayerbes M, Iglesias-Díaz P, Díaz-Prado S, Ayude D, Medina V, Haz M, Reboredo M, Antolín S, Calvo L, Antón-Aparicio LM. Valladares-Ayerbes M, et al. Among authors: reboredo m. J Cancer Res Clin Oncol. 2009 Sep;135(9):1185-95. doi: 10.1007/s00432-009-0559-7. Epub 2009 Feb 17. J Cancer Res Clin Oncol. 2009. PMID: 19221791 Free article. Clinical Trial.
Evaluation of plakophilin-3 mRNA as a biomarker for detection of circulating tumor cells in gastrointestinal cancer patients.
Valladares-Ayerbes M, Díaz-Prado S, Reboredo M, Medina V, Lorenzo-Patiño MJ, Iglesias-Díaz P, Haz M, Pértega S, Santamarina I, Blanco M, Quindós-Varela M, Figueroa A, Antón-Aparicio LM. Valladares-Ayerbes M, et al. Among authors: reboredo m. Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1432-40. doi: 10.1158/1055-9965.EPI-10-0123. Epub 2010 May 25. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20501752 Free article.
Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer.
Valladares-Ayerbes M, Blanco-Calvo M, Reboredo M, Lorenzo-Patiño MJ, Iglesias-Díaz P, Haz M, Díaz-Prado S, Medina V, Santamarina I, Pértega S, Figueroa A, Antón-Aparicio LM. Valladares-Ayerbes M, et al. Among authors: reboredo m. Int J Mol Sci. 2012;13(4):4367-4387. doi: 10.3390/ijms13044367. Epub 2012 Apr 5. Int J Mol Sci. 2012. PMID: 22605983 Free PMC article.
Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in "suboptimal" patients with advanced gastric cancer (AGC). TTD 08-02.
Rivera F, Massutí B, Salcedo M, Sastre J, Martínez Galán J, Valladares-Ayerbes M, Serrano R, García de Paredes ML, Manzano JL, Galán M, Alsina M, Yuste Izquierdo AL, López C, Díaz-Rubio E, Conde V, Reboredo M, Cano MT, Pachón V, Aranda E. Rivera F, et al. Among authors: reboredo m. Cancer Chemother Pharmacol. 2015 Feb;75(2):319-24. doi: 10.1007/s00280-014-2641-3. Epub 2014 Dec 10. Cancer Chemother Pharmacol. 2015. PMID: 25491381 Clinical Trial.
Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen.
Gómez-Martin C, Sánchez A, Irigoyen A, Llorente B, Pérez B, Serrano R, Safont MJ, Falcó E, Lacasta A, Reboredo M, Aparicio J, Dueñas R, Muñoz ML, Regueiro P, Sanchez-Viñes E, López RL. Gómez-Martin C, et al. Among authors: reboredo m. Clin Transl Oncol. 2012 Sep;14(9):689-97. doi: 10.1007/s12094-012-0858-3. Epub 2012 Jul 19. Clin Transl Oncol. 2012. PMID: 22855151 Clinical Trial.
97 results